CHICAGO – French bioinformatics startup SeqOne wants to help laboratories in its home country accelerate testing for SARS-CoV-2 by repurposing its next-generation sequencing data-analysis software.
The company said that by using its approach alongside a newly developed high-throughput viral sequencing protocol, NGS labs will be able to process tens of thousands of tests per day.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
